Houston Methodist — Houston, Texas

Public research footprint of Houston Methodist, compiled from the ClinicalTrials.gov public registry.

1,045

Registered studies

481

Active

237

Recruiting now

388

Completed

123

Stopped or withdrawn

Most-studied conditions

Recurrent Ovarian Carcinoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Anatomic Stage II Breast Cancer AJCC v8 · Recurrent Platinum-Resistant Fallopian Tube Carcinoma

Recently updated registry entries

NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)
NCT05654922 — Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in… (Recruiting)
NCT04181060 — Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Houston Methodist?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.